Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression

被引：3
|
作者：
Ginetta Collo [1 ,2 ]
Emilio Merlo Pich [3 ,4 ]
机构：
[1] Department of Molecular and Translational Medicine,Section of Pharmacology,University of Brescia
[2] Department of Biomedicine,University of Basel
[3] Neuroscience Therapeutic Area Unit,Takeda Pharmaceuticals International
来源：
Neural Regeneration Research | 2018年 / 13卷 / 04期
关键词：
MEK; ERK; Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression; TRD; MDD;
D O I：
暂无
中图分类号：
R749.4 [情感性精神病];
学科分类号：
100205 ;
摘要：
Depression refers to a series of mental health issues characterized by loss of interest and enjoyment in everyday life,low mood and selected emotional,cognitive,physical and behavioral symptoms.Depression is a common disorder,affecting 5–15%of the general population.When diagnosed as major depressive disorder(MDD),patients are currently
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [21] Ketamine is effective in an animal model of treatment-resistant depression
    Pereira, V.
    Joca, S.
    Wegener, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S373 - S373
  • [22] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Ribeiro, Carolina Medeiros da Frota
    Riva-Posse, Patricio
    CURRENT PSYCHIATRY REPORTS, 2017, 19 (12)
  • [23] Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
    Mathew, Sanjay J.
    Shah, Asim
    Lapidus, Kyle
    Clark, Crystal
    Jarun, Noor
    Ostermeyer, Britta
    Murrough, James W.
    CNS DRUGS, 2012, 26 (03) : 189 - 204
  • [24] Personalized use of ketamine and esketamine for treatment-resistant depression
    Medeiros, Gustavo C.
    Demo, Isabella
    Goes, Fernando S.
    Zarate Jr, Carlos A.
    Gould, Todd D.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
  • [25] The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
    Serafini, Gianluca
    Howland, Robert H.
    Rovedi, Fabiana
    Girardi, Paolo
    Amore, Mario
    CURRENT NEUROPHARMACOLOGY, 2014, 12 (05) : 444 - 461
  • [26] How effective are ketamine or esketamine in treatment-resistant depression?
    Veluri, N.
    Mansuri, Z.
    EUROPEAN PSYCHIATRY, 2021, 64 : S330 - S330
  • [27] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
    Rivas-Grajales, Ana Maria
    Salas, Ramiro
    Robinson, Meghan E.
    Qi, Karen
    Murrough, James W.
    Mathew, Sanjay J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 383 - 391
  • [28] Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
    Galuszko-Wegielnik, Maria
    Chmielewska, Zuzanna
    Jakuszkowiak-Wojten, Katarzyna
    Wiglusz, Mariusz S.
    Cubala, Wieslaw J.
    BRAIN SCIENCES, 2023, 13 (01)
  • [29] Ketamine infusions for treatment-resistant bipolar depression: Commentary
    Vazquez, Gustavo H.
    Baldessarini, Ross J.
    BIPOLAR DISORDERS, 2023, 25 (05) : 431 - 432
  • [30] An exploration of actigraphy in the context of ketamine and treatment-resistant depression
    Punturieri, Claire
    Duncan, Wallace C., Jr.
    Greenstein, Dede
    Shandler, Gavi
    Zarate, Carlos A., Jr.
    Evans, Jennifer W.
    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2024, 33 (01)
12345